A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults
一项评估不同加强免疫方案的 2013 年和 2017 年 A(H7N9) 灭活流感病毒疫苗在健康美国成年人中安全性、反应原性和免疫原性的 II 期临床试验，疫苗分别添加和不添加 AS03 佐剂。
期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciae173
Rostad, Christina A; Atmar, Robert L; Walter, Emmanuel B; Frey, Sharon; Meier, Jeffery L; Sherman, Amy C; Lai, Lilin; Tsong, Rachel; Kao, Carol M; Raabe, Vanessa; El Sahly, Hana M; Keitel, Wendy A; Whitaker, Jennifer A; Smith, Michael J; Schmader, Kenneth E; Swamy, Geeta K; Abate, Getahun; Winokur, Patricia; Buchanan, Wendy; Cross, Kaitlyn; Wegel, Ashley; Xu, Yongxian; Yildirim, Inci; Kamidani, Satoshi; Rouphael, Nadine; Roberts, Paul C; Mulligan, Mark J; Anderson, Evan J
